Director of Research

Dr. Goddard joined Tal Medical in 2015, with the goal of directing the ongoing basic research effort, expanding studies to understand LFMS mechanism of action, and optimizing the treatment. Prior to joining Tal, he was at the Novartis Institute of Biomedical Research, where he was a group leader in the Neuroscience drug discovery unit. His main research focus is in understanding how brain circuits are organized and how they convey information in both the diseased and otherwise healthy brain. He has deep experience in multiple levels of analysis within neuroscience, from molecular and cellular approaches to electrophysiological investigations of the brain at a systems level.

Dr. Goddard has degrees in Neuroscience and Biochemistry from Oberlin College. He received his Ph.D. from Harvard University in the lab of Carla Shatz, where he worked on how the immune molecule, MHCI, was contributing to activity-dependent synapse formation and plasticity in the developing brain. In his postdoctoral work at Stanford, he pioneered microcircuit approaches to studying attention-related networks in the mid-brain with Eric Knudsen and John Huguenard.